high-throughput
(2)
N1
N1 (formerly Layer N) is a high-performance Layer-1 blockchain built specifically for onchain finance at scale. Founded by DeFi veterans Dima Romanov, David Cao, and Sheheryar Parvaz, N1 pairs an ultra-low-latency, congestion-free execution layer with native financial primitives - an onchain orderbook, atomic transaction bundles, unified margining, and RFQ - so that trading applications that previously had to run offchain can run natively onchain. Every app runs in its own isolated environment with no state congestion, and developers can write smart contracts in TypeScript (with Python and other languages on the way). Backed by Founders Fund, Multicoin Capital, dao5, Kraken Ventures, and Arthur Hayes, the New York-based team is targeting the performance ceiling that has kept serious finance from moving onchain.
Shennon Biotechnologies
Shennon Biotechnologies is a San Francisco biotech turning immune-cell target discovery from a months-long slog into a same-day job. Its proprietary TCELERATOR platform fuses ultra-high-throughput microfluidics with AI to functionally profile millions of single immune cells in hours, pinpointing the rare T and B cells that recognize cancer antigens. Founded in 2021 by physicist-turned-founder Li Sun, the company is building a pipeline of validated targets for solid tumors and autoimmune disease, backed by a $13M seed round led by DCVC.